Abstract
Pulmonary arterial hypertension (PAH) is characterized by endothelial cell (EC) dysfunction. There are no data from living patients to inform whether differential gene expression of pulmonary artery ECs (PAECs) can discern disease subtypes, progression and pathogenesis. We aimed to further validate our previously described method to propagate ECs from right heart catheter (RHC) balloon tips and to perform additional PAEC phenotyping. We performed bulk RNA sequencing of PAECs from RHC balloons. Using unsupervised dimensionality reduction and clustering we compared transcriptional signatures from PAH to controls and other forms of pulmonary hypertension. Select PAEC samples underwent single cell and population growth characterization and anoikis quantification. Fifty-four specimens were analyzed from 49 subjects. The transcriptome appeared stable over limited passages. Six genes involved in sex steroid signaling, metabolism, and oncogenesis were significantly upregulated in PAH subjects as compared to controls. Genes regulating BMP and Wnt signaling, oxidative stress and cellular metabolism were differentially expressed in PAH subjects. Changes in gene expression tracked with clinical events in PAH subjects with serial samples over time. Functional assays demonstrated enhanced replication competency and anoikis resistance. Our findings recapitulate fundamental biological processes of PAH and provide new evidence of a cancer-like phenotype in ECs from the central vasculature of PAH patients. This "cell biopsy" method may provide insight into patient and lung EC heterogeneity to advance precision medicine approaches in PAH.
Introduction
Pulmonary arterial hypertension (PAH) is a progressive, often fatal disease characterized by high blood pressure in the lung's arteries, driven largely by the dysfunction of endothelial cells (ECs). Historically, studying these cells in humans has been a major bottleneck. Researchers usually rely on post-mortem tissue (representing end-stage disease), lung transplants, or stem-cell-derived models. The gap is clear: we lack a way to observe how these cells behave and change in living patients as the disease evolves or responds to therapy. This study addresses this by refining a method to "biopsy" cells during a standard diagnostic procedure, providing a window into the active pathobiology of the disease.
Methodology
The researchers utilized a multi-disciplinary approach combining clinical procedure, cell biology, and bioinformatics. Endothelial cells were harvested from the balloons of Right Heart Catheters (RHC) used during routine clinical care. The team performed bulk RNA sequencing on these pulmonary artery endothelial cells (PAECs) at early stages (passages 3–4) to ensure the genetic signature remained stable and representative of the patient's internal state.
To move beyond transcriptomics, they performed functional assays including single-cell cloning and anoikis assays. Anoikis is a form of programmed cell death that occurs when a cell detaches from the extracellular matrix; resistance to this process is a hallmark of cancer. Bioinformatics analysis involved unsupervised dimensionality reduction (PCA) and clustering to compare PAH signatures against controls and other forms of pulmonary hypertension. The study analyzed 54 specimens from 49 subjects, including Group 1 PAH (idiopathic, heritable, and associated forms), Groups 2–5 PH, and controls.
Results
The Cancer-Like Phenotype
One of the most striking findings was the "cancer-like" behavior of PAH cells. Specifically, cells from patients with heritable PAH showed significant resistance to anoikis and enhanced replication competency. In suspension assays, approximately 5% of PAH-derived cell colonies survived, demonstrating clear anoikis resistance, whereas control cells typically died. The gene PLAC8 was identified as a potential driver of this hyper-proliferative state.
Transcriptional Signatures and Plasticity
The researchers identified 667 differentially expressed genes in PAH subjects compared to controls. Six specific genes involved in sex steroid signaling, metabolism, and oncogenesis—including CFAP92 and SNORA4—were significantly upregulated. Conversely, key pathways related to BMP signaling (GATA4, ACVR1) and Wnt signaling (CTNND1), both critical for vascular health, were downregulated.
By tracking patients over time, the team showed that gene expression is not static. In one patient with portopulmonary hypertension (PoPH), the "diseased" gene signature effectively "normalized" toward a control pattern after a successful liver transplant. Interestingly, the study found that different types of pre-capillary pulmonary hypertension (Groups 1 and 3–5) shared similar transcriptional profiles, suggesting common molecular mechanisms might underpin vascular remodeling regardless of the initial clinical trigger.
Discussion and Future Directions
While PAH is often considered a disease of the microscopic distal vessels, this study proves that cells from the proximal (larger) pulmonary arteries carry the disease's signature, suggesting the entire vascular tree is involved. However, the authors acknowledge limitations, such as potential selection bias during cell culture and the difficulty of ensuring 100% arterial cell purity from the RHC balloon.
Future work is moving toward single-cell sequencing to explore the heterogeneity within a single patient's "cell biopsy." This platform holds promise for precision medicine, potentially allowing clinicians to test how a specific patient's cells respond to different drugs in the lab before prescribing them.
Summary updated